FDA Grants Historic Approval for Gene-Editing Treatment in Sickle Cell Disease The US Food and Drug Administration approved a groundbreaking gene-editing therapy for sickle cell disease, which affects hundreds of thousands of Americans. by Quincy Jon
Health Sickle Cell Disease: Could CRISPR’s Gene Therapy Editing Tech be the First Cure for It? by Isaiah Richard
Science Sickle Cell Disease Can Now be Cured Through CRISPR-Based Gene-Editing Treatment by Sieeka Khan